series-b
Stage
About
Proniras Corporation is a clinical-stage biotechnology company developing small-molecule therapeutics for the treatment of substance use disorders and central nervous system conditions, including opioid withdrawal and seizure disorders.
Explore Proniras Corporation's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.